← Leaderboards
Andrew Marshall
Healionics Corporation
$7,532,215
Attributed
$9,242,860
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,242,860 · 9
By mechanism
R44$7,143,446 · 4
SB1$1,243,795 · 1
R43$855,619 · 4
Top collaborators
- Nam T Tran4 shared
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesSurfaceDevicesInfectionInnovationSmall Business Innovation Research GrantPerformanceBiocompatible MaterialsBlood VesselsVenousHemodialysisMaintenanceMechanicsDesignNeedlesResistanceImplantArteriovenous FistulaDialysis ProcedureEnd Stage Renal FailureCathetersSheepSkinBlood Circulation
Grant awards (18)
Commercial and Regulatory Development of an Enhanced Performance Hemodialysis Access Graft$290,351
SB1 · FY2025 · HL · contact PI
Commercial and Regulatory Development of an Enhanced Performance Hemodialysis Access Graft$953,444
SB1 · FY2024 · HL · contact PI
Product and Regulatory Development of a Needle-Free Hemodialysis Access Port$984,472
R44 · FY2021 · HL · contact PI
Product and Regulatory Development of a Needle-Free Hemodialysis Access Port$997,847
R44 · FY2020 · HL · contact PI
Product and Regulatory Development of a Needle-Free Hemodialysis Access Port$998,633
R44 · FY2019 · HL · contact PI
Infection Resistant Hemodialysis Access Graft$224,815
R43 · FY2019 · DK · contact PI
Clinical Study of an Extended-Patency Dialysis Access Graft$440,339
R44 · FY2017 · DK · contact PI
Biointegrating Dialysis Access Graft with Self Stabilizing Flow$280,674
R44 · FY2017 · DK · contact PI
Infection and Thrombosis Resistant Needle-Free Hemodialysis Access Port and Graft Using STAR Biomaterials$142,446
R44 · FY2017 · HL · contact PI
Biointegrating Dialysis Access Graft with Self Stabilizing Flow$633,578
R44 · FY2016 · DK · contact PI
Infection and Thrombosis Resistant Needle-Free Hemodialysis Access Port and Graft Using STAR Biomaterials$595,657
R44 · FY2016 · HL · contact PI
Biointegrating Dialysis Access Graft with Self Stabilizing Flow$581,096
R44 · FY2015 · DK · contact PI
Infection and Thrombosis Resistant Needle-Free Hemodialysis Access Port and Graft Using STAR Biomaterials$579,539
R44 · FY2015 · HL · contact PI
Vascular Grafts for Needle Free Dialysis Access Devices.$224,499
R43 · FY2014 · DK · contact PI
Fibrosis-Resistant Bleb-Free Gaucoma Implant$206,540
R43 · FY2014 · EY · contact PI
Anti-Infective Dermal Integration Sleeves for Needle Free Dialysis Access Devices$461,247
R44 · FY2013 · GM · contact PI
Anti-Infective Dermal Integration Sleeves for Needle Free Dialysis Access Devices$447,918
R44 · FY2012 · GM · contact PI
Dermal Integration Sleeve to Reduce Exit Site Infections.$199,765
R43 · FY2010 · GM · contact PI